Enanta Pharmaceuticals Inc (ENTA)
5.71
-0.15
(-2.56%)
USD |
NASDAQ |
Mar 28, 16:00
5.70
-0.01
(-0.18%)
After-Hours: 20:00
Enanta Pharmaceuticals Profit Margin (Quarterly): -131.4% for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Recursion Pharmaceuticals Inc | -3.97K% |
| Moderna Inc | -117.2% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -70.18% |
| Return on Assets | -26.68% |
| Return on Invested Capital | -70.18% |
| Operating Margin (Quarterly) | -138.8% |
| Return on Net Operating Assets | -103.4% |